PLAINVIEW, N.Y., Nov. 14, 2024 (GLOBE NEWSWIRE) — Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading medtech company with a diversified business portfolio in network and healthcare IT services, professional sales services, and proprietary medical products, today reported its operating results for the three months ended September 30, 2024. “For the third quarter of 2024, the...
Read More

PLAINVIEW, N.Y., Aug. 26, 2024 — Vaso Corporation (“Vaso”) (OTCQX: VASO) today announced that at its special stockholders meeting on August 26, 2024, the meeting was adjourned without any consideration of the proposals to 10:00 AM Eastern on September 10, 2024 at the same location, the Lever House located at 390 Park Avenue, New York, NY...
Read More

High deferred revenue and backlog setting stage for 2024 revenue and income growth PLAINVIEW, N.Y., Aug. 14, 2024 (GLOBE NEWSWIRE) — Vaso Corporation (“Vaso”) (OTCQX: VASO) today reported its operating results for the three months ended June 30, 2024. “The Company recorded a total revenue of $20.2 million for the second quarter of 2024, in line with revenue of $20.3 million for the second...
Read More

A significant milestone for Vaso’s Listing on NASDAQ Vaso Stockholders Meeting Scheduled for August 26, 2024 to Approve Business Combination with Achari PLAINVIEW, N.Y., Aug. 07, 2024 (GLOBE NEWSWIRE) — Vaso Corporation (“Vaso” or the “Company”) (OTCQX: VASO) announced that on August 5, 2024, the U.S. Securities and Exchange Commission (“SEC”) declared effective the Achari Ventures Holdings Corp. I (“Achari”) (NASDAQ: AVHI) Registration Statement...
Read More

PLAINVIEW, N.Y., May 15, 2024 (GLOBE NEWSWIRE) — Vaso Corporation (“Vaso”) (OTCQX: VASO) today reported its operating results for the three months ended March 31, 2024. “Total revenue for the first quarter of 2024 was $18.7 million, a decrease of $0.3 million or 1.6% when compared to the same quarter last year, mainly due to...
Read More